3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
21
Lung Neoplasms
10
Stomach Neoplasms
9
Neoplasm Metastasis
8
Breast Neoplasms
8
Esophageal Neoplasms
7
Colorectal Neoplasms
6
Small Cell Lung Carcinoma
5
Pancreatic Neoplasms
5
Leukemia, Myeloid, Acute
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Nasopharyngeal Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Adenocarcinoma Of Esophagus
4
Uterine Cervical Neoplasms
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Mouth Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Glioma
2
Endometrial Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Ovarian Epithelial
2
Anus Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Interventions
Cyclophosphamide
25
fludarabine
19
Dexamethasone
17
pembrolizumab
13
Rituximab
12
venetoclax
9
Lenalidomide
9
Gemcitabine
9
Etoposide
9
pomalidomide
8
Vincristine
7
glofitamab
6
fludarabine phosphate
6
carfilzomib
6
Temozolomide
6
obinutuzumab
5
daratumumab
5
Prednisone
5
Nivolumab
5
Doxorubicin
5
Cisplatin
5
Calcium Dobesilate
5
Bortezomib
5
zanubrutinib
4
selinexor
4
Immunotherapy, Adoptive
4
Cytarabine
4
Carboplatin
4
Azacitidine
4
ruxolitinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Drug Therapy
×
90 days
×
Clear all
No trials found.